Measles control and elimination in the Eastern Mediterranean Region

Slides:



Advertisements
Similar presentations
Global Measles and Rubella Strategic Plan
Advertisements

World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Towards Measles Elimination in the Western Pacific Region.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Regional Progress Towards Measles and Rubella Elimination Tenth Annual Measles Initiative Meeting September 13-14, 2011 Washington, DC Sergei Deshevoi.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Measles and Rubella Elimination in the WHO European Region: Update on Progress & Challenges Global Measles and Rubella Management Meeting March 2011.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Strengthening Routine Infant Immunization in EMR Partners for Measles Advocacy February, 2007 Eastern Mediterranean Regional Office Vaccines Preventable.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
Epidemiology of Vaccine Preventable diseases in Iran
Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.
Measles in EMR 7 th Annual Meeting of Partners for Measles Advocacy Washington, 2007.
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Update on Measles Mortality Reduction Activities and Linkages with RI.
Measles Initiative Management and Financing September 13, 2011.
8 th Global Measles and Rubella LabNet Meeting, Sept 2010 Key Recommendations GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Salle B, WHO.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
World Health Organization Eastern Mediterranean Region.
Funding Update: 2013 – 2015 September 10,
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
Regional measles elimination program updates B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
12 th Annual Meeting The Measles & Rubella Initiative Western Pacific Regional Update: The Final Push September 2013 American Red Cross National.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Midterm Review Update Global Measles and Rubella Strategic Plan 2012 – 2020 W. A. Orenstein, MD Measles and Rubella Management Meeting, Geneva, June 2016.
Measles and Measles Outbreaks in China Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting Geneva, Switzerland June 19,
Accelerating Progress towards Measles and Rubella Elimination WHO Western Pacific Region UNICEF East Asia and Pacific Region 1 21 June 2016 Geneva, Switzerland.
Accelerating Progress towards Measles and Rubella Elimination Eastern Mediterranean Region 1 21 June 2016 Geneva, Switzerland.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
World Health Organization
Journey For Scaling up Family Practice
Global Overview of Measles
53 Member States >900 million inhabitants WHO European Region
World Health Organization
Accelerating Progress Towards Measles and Rubella
World Health Organization
World Health Organization
Session 1: New Opportunities and New Direction
مراقبت بيماريهاي بثوري تب دار باهدف حذف سرخك و سرخجه
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
African Region- priorities to reach the 2020 measles elimination goal.
Funding Update: Current Situation and Future Prospects
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Partners for Measles Advocacy—7th Annual Meeting
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
World Health Organization
Presentation transcript:

Measles control and elimination in the Eastern Mediterranean Region Nadia Teleb MD, MPH, Dr.PH Regional Adviser, Vaccine Preventable Diseases and Immunization WHO/EMRO

The Eastern Mediterranean Region Palestine Bahrain Pop: 555 Million LB: 16.4 Million GAVI eligible: 7 countries, 56% LMIC: 7 countries, 38.5% UMIC: 3 countries, 2.5% HIC: 6 countries, 3% of LB

Outline Regional targets Regional strategy Progress in implementation of the regional strategy Progress towards achieving the target Plans 2011-2012 Challenges and opportunities

Measles related targets in the EMR Measles elimination from all countries by 2010 (resolution EM/RC44/R.6, 1997) Target date revised to 2015 (EPI managers’ meeting , July 2010) Measles Mortality reduction target: EMR adopts the global target

Regional Strategy to achieve measles control/elimination in the EMR Achieving high population immunity: Nationwide measles catch-up vaccination campaign, achieving homogenous high coverage sustaining population immunity through high vaccination coverage (≥95% coverage in all districts) with 2 doses of MCV; preferably during the second year of life: Routine MCV1; AND Second dose: routine second dose and/or Periodic follow-up SIAs which should continue until achieving the high routine coverage for MCV1 and MCV2 Strong case-based lab surveillance Case management

Progress in implementation of the regional strategy 1 Progress in implementation of the regional strategy 1. Measles vaccination

MCV1/MCV2 Schedule/type of vaccine, EMR, 2011 Country MCV1 MCV2 Type Age Afghanistan M 9 m 15-18 m Bahrain MMR 12 m 5y Djibouti Egypt 18 m Iran Iraq 15m, 4-6y Jordan Kuwait 2y, 12y Lebanon 4-6 y Libya Morocco Oman Pakistan 9m Palestine 12m, 18 m Rubella 12Y Qatar Saudi Arabia 12m, 4-6 y Somalia Sudan S. Sudan 9M Syria Tunisia R 15 m 12y 6 y UAE Yemen EMR MCV1 @ 9m: 7 countries/ MCV2 18 countries, / R in 15 countries/ MMR2: 14 Countries

Source: JRF 2010

Reported district coverage of MCV1, 2010 Target 95% in all districts Improving routine immunization: RED approach in AFG, IRQ, PAK, SOM, SUD, YEM CHDs in Somalia Acceleration campaigns in SUD, AFG Vaccination week of the EMR Coverage% Source: JRF 2010

Measles vaccination strategies in the EMR 2. Supplementary immunization activities (SIAs) Palestine Bahrain High routine coverage Response campaigns Follow up campaigns Catch-up campaigns implemented in all countries Around 400 million people vaccinated 1994-2010 through SIAs 10

Measles SIAs in EMR 2010-2011

Progress in implementation of the regional strategy 2 Progress in implementation of the regional strategy 2. Measles surveillance

Measles Case-Based Surveillance in EMR, 2011 Palestine Bahrain Nation-wide Measles Case-based surveillance (19) Moving to Nation-wide measles surveillance (1) Sentinel sites measles surveillance (3)

Measles Laboratory Network in the EMR, 2011 Palestine Bahrain Serology capacity only (6) Serology and virus detection/isolation capacity (11) Serology and virus detection/isolation and sequencing capacity (6) Regional Reference Laboratories

No genotype data from 4 countries: PAL, LEB, S.SUD, UAE

Measles surveillance performance indicators in the EMR 2010 2009 2008 2007 2006 2005 Indicator 86% 72% 77% 80% 57% 75% % of countries ≥80% of suspected cases tested 100% 95% 91% 68% % of countries ≥80% cases with complete investigated 73% 70% 36% 50% % of countries with ≥80% specimen received at lab 7day of collection 96% 89% % of countries with ≥80% adequate specimens 81% 90% 58% % of countries with ≥80% results reported within 7 days 42% 52% 22% Zero% % of countries that achieved the reporting rate ≥2 /100,000 population at national level 27% 9% 4% % of countries that achieved the reporting rate ≥1 /100,000 population at all sub-national level

Rubella & CRS Surveillance system situation in EMR Measles vaccination strategies in the EMR 2. Supplementary immunization activities (SIAs) Palestine Bahrain Rubella testing and CRS system (9 countries) Rubella testing only (12countries) None (2countries) 17

Geographic distribution of rubella cases in the EMR countries by district and final diagnosis between July 2010 and June 2011 The source of data in this slide is country measles surveillance DEFs received on monthly basis from countries 18

Progress towards achieving the target

Estimated measles deaths 93% 90%

Progress in Measles elimination in the EMR 88% reduction in reported cases between 1998 to 2010 8 countries close to elimination in 2010 Source: Country reports Inadequate surveillance

Geographic distribution of measles cases in the EMR countries by district and final diagnosis between July 2010 and June 2011 Source : Official countries’reports

Progress In Eastern Mediterranean Region Achieving the target: Measles mortality reduction target achieved 3 years ahead Sustainability is threatened Measles Elimination target goal by 2010 was not reached 8 countries are close to elimination Target date postponed to 2015 Measles case-based surveillance in 20 countries, expanding in 3 countries Regional guidelines for elimination validation developed, field tested and officialised Regional Validation Commission was formulated National validation committee established in 5 countries, others are in the process

Future plans Supporting improving population immunity Continue strengthening routine immunization: RED approach, CHDs Introduction of MCV2 in Sudan Nov. 2011 Timely follow up SIAs Strengthening Measles surveillance: Case based surveillance in Somalia and S. Sudan Improving surveillance indicators to reach requirements of validation indicators Preparing for validation of elimination in the ready countries

Planned SIAs for 2011 and funding requirement

Financial support from international partners Challenges Opportunities Funding: specially for the follow-up campaigns FU campaigns needed in 7 countries Target:> 95 million for 2011-2015 National managerial Capacity: Inadequate number and qualification of staff Devolution in Pakistan Competing priorities: Polio eradication Other EPI issues: NVI,.. Pockets of susceptible populations/groups Hard to reach populations in low income countries Pockets in countries with big expatriate population Security situation: rapidly deteriorating in the EMR Delayed implementation of planned activities Financial support from international partners Interest of the countries Renewing commitment: EPI technical paper submitted to RC October 2011 Polio infrastructures

Summary Remarkable progress in measles mortality reduction, Measles elimination was not achieved in time, More efforts are needed with the current political turmoil and security situation in some countries Bridging funding gaps to support LIC countries is challenging

Acknowledgements Partners of the Measles initiative CDC Atlanta EMR RRLs in Tunisia and Oman VIDRL Australia EMR EPI staff, lab network WHO/HQ